ABN AMRO Investment Solutions’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.9M | Buy |
150,297
+31,000
| +26% | +$12.6M | 1.22% | 20 |
|
|
2025
Q1 | $59.4M | Sell |
119,297
-622
| -0.5% | -$310K | 1.24% | 24 |
|
|
2024
Q4 | $62.4M | Buy |
119,919
+19,856
| +20% | +$10.3M | 1.16% | 24 |
|
|
2024
Q3 | $61.9M | Sell |
100,063
-3,148
| -3% | -$1.95M | 1.08% | 26 |
|
|
2024
Q2 | $57.1M | Sell |
103,211
-25,693
| -20% | -$14.2M | 1.04% | 26 |
|
|
2024
Q1 | $74.9M | Sell |
128,904
-13,032
| -9% | -$7.57M | 1.3% | 22 |
|
|
2023
Q4 | $75.3M | Buy |
141,936
+19,185
| +16% | +$10.2M | 1.32% | 23 |
|
|
2023
Q3 | $62.1M | Buy |
122,751
+9,152
| +8% | +$4.63M | 1.22% | 21 |
|
|
2023
Q2 | $59.3M | Sell |
113,599
-1,916
| -2% | -$1,000K | 1.19% | 25 |
|
|
2023
Q1 | $66.6M | Buy |
+115,515
| New | +$66.6M | 1.37% | 15 |
|